...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What’s the point - short interest doubled lol
Reply New Message
Prev Message Back To Forum Threaded View Next Message
SHORT INTEREST
DATE
SHORT INTEREST
% CHANGE
AVG. DAILY SHARE VOL
SPLIT
NEW ISSUE
02/29/2024 4,304 85.12 8,583 No No
02/15/2024 2,325 0.00 16,023 No No
01/31/2024 2,325 0.00 57,645 No No
01/12/2024 2,325 -46.04 44,369 No No
12/29/2023 4,309 0.00 53,696 No No
12/15/2023 4,309 85.33 16,033 No No
11/30/2023 2,325 0.00 13,334 No No
11/15/2023 2,325 0.00 5,932 No No
10/31/2023 2,325 0.00 13,910 No No
10/13/2023 2,325 0.00 14,873 No No
The short interest is totally irrelevant anyway so why pull  this bonkers move,?How much money could be made , scabby.Bizzare imo.
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply